Authors
Li Pang, Yutian Lin, Tao Ding, Kenglong Huang, Leibo Xu, Chao Liu, Donglin Tan, Dayang Hui, Wenrui Wu
Published in
Transplantation. Nov 12, 2026. Epub Nov 12, 2026.
Abstract
Immune checkpoint inhibitor-related T-cell-mediated rejection (irTCMR) leads to greater steroid resistance and graft loss compared with conventional T-cell-mediated rejection (cTCMR) in liver transplant recipients. However, their histopathological and transcriptomic features remain poorly understood.
Thirty-one adult recipients with biopsy-proven T-cell-mediated rejection (12 irTCMR and 19 cTCMR) were enrolled. Biopsies were assessed using the Banff and Ishak scoring systems, with immunohistochemical staining for CD3, CD4, CD8, CD20, programmed death-ligand 1, and C4d. Spatial transcriptomic analysis was performed on the CD45-enriched portal areas.
irTCMR showed higher alanine aminotransferase/aspartate aminotransferase peaks, steroid-resistant rejection (33.3% versus 0%; P = 0.016), and graft loss (41.7% versus 0%; P = 0.005). IrTCMR had a higher rejection activity index (median 6 versus 5; P = 0.020), driven by more severe bile duct inflammation and venous endothelialitis. Ishak scoring revealed a higher histological activity index with greater confluent necrosis (P = 0.046). Both groups showed CD8+ predominant T-cell aggregates with sparse CD20+ B cells; CD4+ abundance (P = 0.079) and the CD4/CD8 ratio (P = 0.096) tended to be higher in irTCMR. Portal C4d deposition and programmed death-ligand 1 expression showed no significant differences. Spatial transcriptomics revealed distinct transcriptomic profiles in irTCMR, with 75 differentially expressed genes and enrichment of allograft rejection and antigen processing pathways. Immune deconvolution demonstrated increased CD4+ T cells, dendritic cells, and M1 macrophages but reduced regulatory T cells in irTCMR.
irTCMR is a distinct aggressive rejection phenotype with severe bile duct inflammation, venous endothelialitis, confluent necrosis, and transcriptomic features distinct from cTCMR. These features underscore the need for further research on the pathogenesis of irTCMR.
PMID:
43038106
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0